文献速递前列腺癌

微滤捕获尿液细胞DNA甲基化分析无创检测高级别前列腺癌

Noninvasive Detection of High Grade Prostate Cancer by DNA Methylation Analysis of Urine Cells Captured by Microfiltration.
PubMed 文献 · J Urol · 2018-04-24

本研究前瞻性收集99例直肠指检前、58例直肠指检后及7例导尿管尿液,用8μm微滤膜捕获细胞并以ddPCR检测5种DNA甲基化标志物。前列腺癌诊断率71%,指检前和指检后样本灵敏度分别为81%和60%;指检后样本联合PSA、年龄预测高级别病变(Gleason≥7)AUC为0.95(95%CI 0.90-1.00)。

要点

  • 微滤捕获尿液细胞DNA甲基化可无创检测前列腺癌,高级别病变灵敏度高
  • 直肠指检后尿液样本联合PSA和年龄预测高级别病变AUC达0.95
  • 重复采样可提高灵敏度,尤其未经前列腺物理操作时

核心结论

  • 微滤捕获尿液细胞行DNA甲基化分析可无创检测前列腺癌,对高级别病变灵敏度高。

研究设计与样本

  • 用8μm滤膜从全量排尿中捕获细胞,ddPCR检测5种甲基化标志物。

主要发现

  • 117例(71%)诊断为前列腺癌。
  • 所有肿瘤级别中,指检前和指检后尿液DNA检测灵敏度分别为81%和60%。
  • 指检后样本联合PSA、年龄预测高级别病变(Gleason≥7)AUC为0.95(95%CI 0.90-1.00)。
  • 重复样本显示个体内癌细胞脱落存在显著变异。

关键数值与推荐

  • 高级别病变定义为Gleason评分≥7。
  • 预测模型包含PSA、患者年龄和尿液DNA分析结果。

临床怎么用

  • 可作为疑似前列腺癌患者的无创检测手段,尤其针对高级别病变;指检后尿液联合PSA和年龄可提高预测准确性。
  • 重复采样可能提高灵敏度,尤其未行前列腺物理操作时。

局限性

  • 重复采样显示个体内癌细胞脱落变异大,可能影响单次检测灵敏度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: With the aim of developing a noninvasive test to detect clinically significant prostate cancer we investigated the potential of capturing cells from urine by microfiltration coupled with analysis of DNA methylation biomarkers. MATERIALS AND METHODS: In this prospective study urine from men suspected of having prostate cancer who were scheduled for transrectal ultrasound guided biopsy of the prostate was collected before digital rectal examination in 99, after digital rectal examination in 58 and from a urethral catheter in 7. Cells were isolated from whole volume voided urine using a filtration device containing a membrane filter with a pore size of 8 μm. Ten additional men provided 4 or 5 urine cell samples by self-collection prior to biopsy. Cellular DNA was analyzed for 5 methylation biomarkers using ddPCR™ (droplet digital polymerase chain reaction). RESULTS: Prostate cancer was diagnosed in 117 patients (71%). Across all tumor grades the sensitivity of urine DNA testing was 81% and 60% in samples obtained before and after digital rectal examination, respectively. In a prediction model including prostate specific antigen, patient age and the result of urine DNA analysis to detect high grade disease (Gleason score 7 or greater) an AUC of 0.95 (95% CI 0.90-1.00) was obtained for post-digital rectal examination samples. Analysis of repeat samples demonstrated substantial intraindividual variation in the shedding of cancerous cells in urine. CONCLUSIONS: Capturing cells from urine by microfiltration provides a novel tool to detect prostate cancer noninvasively with high sensitivity for high grade disease. Repeat sampling may increase sensitivity, particularly when urine is obtained without prior physical manipulation of the prostate.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Larsen LK, Jakobsen JS, Abdul-Al A, et al. Noninvasive Detection of High Grade Prostate Cancer by DNA Methylation Analysis of Urine Cells Captured by Microfiltration. J Urol. 2018. PMID: 29702096. doi:10.1016/j.juro.2018.04.067

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。